Large-scale testing (Phase 3)UnknownNCT04490681
What this trial is testing
Validation of ERTugliflozin for Inhibiting Cardiac Fibrosis Using Cardiac MRI and Laboratory Parameters in Korean Heart Failure Patients With Nonischemic Cardiomyopathy(VERTICAL)
Who this might be right for
Heart Failure With Nonischemic Cardiomyopathy
Yonsei University 52